LCN2 and acute kidney injury: In Marcello et al.’s study, 34.7% of patients were diagnosed with CSA-AKI by creatinine rise while 69.4% of patients with subclinical CSA-AKI using the plasmatic neutrophil gelatinase-associated lipocalin (NGAL) [11].